170 related articles for article (PubMed ID: 26657603)
1. Nitric oxide releasing acridone carboxamide derivatives as reverters of doxorubicin resistance in MCF7/Dx cancer cells.
Rajendra Prasad VV; Deepak Reddy G; Kathmann I; Amareswararao M; Peters GJ
Bioorg Chem; 2016 Feb; 64():51-8. PubMed ID: 26657603
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity studies of some novel fluoro acridone derivatives against sensitive and resistant cancer cell lines and their mechanistic studies.
Rajendra Prasad VV; Peters GJ; Lemos C; Kathmann I; Mayur YC
Eur J Pharm Sci; 2011 Jul; 43(4):217-24. PubMed ID: 21565270
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of quinazolinone tagged acridones as cytotoxic agents and their effects on EGFR tyrosine kinase.
Babu YR; Bhagavanraju M; Reddy GD; Peters GJ; Prasad VV
Arch Pharm (Weinheim); 2014 Sep; 347(9):624-34. PubMed ID: 24866341
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, biological evaluation, molecular docking and QSAR studies of 2,4-dimethylacridones as anticancer agents.
Murahari M; Kharkar PS; Lonikar N; Mayur YC
Eur J Med Chem; 2017 Apr; 130():154-170. PubMed ID: 28246041
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiproliferative activity of some novel benzo-fused imidazo[1,8]naphthyridinones.
Giannouli V; Kostakis IK; Pouli N; Marakos P; Samara P; Tsitsilonis O
Bioorg Med Chem Lett; 2015 Jul; 25(13):2621-3. PubMed ID: 25998504
[TBL] [Abstract][Full Text] [Related]
6. Acridone derivatives: design, synthesis, and inhibition of breast cancer resistance protein ABCG2.
Boumendjel A; Macalou S; Ahmed-Belkacem A; Blanc M; Di Pietro A
Bioorg Med Chem; 2007 Apr; 15(8):2892-7. PubMed ID: 17317193
[TBL] [Abstract][Full Text] [Related]
7. Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies.
Murahari M; Prakash KV; Peters GJ; Mayur YC
Eur J Med Chem; 2017 Oct; 139():961-981. PubMed ID: 28886509
[TBL] [Abstract][Full Text] [Related]
8. Elucidation of chemosensitization effect of acridones in cancer cell lines: Combined pharmacophore modeling, 3D QSAR, and molecular dynamics studies.
Gade DR; Makkapati A; Yarlagadda RB; Peters GJ; Sastry BS; Rajendra Prasad VVS
Comput Biol Chem; 2018 Jun; 74():63-75. PubMed ID: 29547875
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of 2-fluoro N(10)-substituted acridones and their cytotoxicity studies in sensitive and resistant cancer cell lines and their DNA intercalation studies.
Mayur YC; ; Peters GJ; Lemos C; Kathmann I; Prasad VV
Arch Pharm (Weinheim); 2009 Nov; 342(11):640-50. PubMed ID: 19856333
[TBL] [Abstract][Full Text] [Related]
10. Chloro acridone derivatives as cytotoxic agents active on multidrug-resistant cell lines and their duplex DNA complex studies by electrospray ionization mass spectrometry.
Rajendra Prasad VV; Venkat Rao J; Giri RS; Sathish NK; Shanta Kumar SM; Mayur YC
Chem Biol Interact; 2008 Nov; 176(2-3):212-9. PubMed ID: 18638463
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of a naturally occurring furoquinoline alkaloid and four acridone alkaloids towards multi-factorial drug-resistant cancer cells.
Kuete V; Fouotsa H; Mbaveng AT; Wiench B; Nkengfack AE; Efferth T
Phytomedicine; 2015 Sep; 22(10):946-51. PubMed ID: 26321744
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 2-methyl N10-substituted acridones as selective inhibitors of multidrug resistance (MDR) associated protein in cancer cells.
Mayur YC; Ahmad O; Prasad VV; Purohit MN; Srinivasulu N; Kumar SM
Med Chem; 2008 Sep; 4(5):457-65. PubMed ID: 18782042
[TBL] [Abstract][Full Text] [Related]
13. Overcoming multidrug resistance by targeting mitochondria with NO-donating doxorubicins.
Gazzano E; Chegaev K; Rolando B; Blangetti M; Annaratone L; Ghigo D; Fruttero R; Riganti C
Bioorg Med Chem; 2016 Mar; 24(5):967-75. PubMed ID: 26822567
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.
Kelly JX; Smilkstein MJ; Cooper RA; Lane KD; Johnson RA; Janowsky A; Dodean RA; Hinrichs DJ; Winter R; Riscoe M
Antimicrob Agents Chemother; 2007 Nov; 51(11):4133-40. PubMed ID: 17846138
[TBL] [Abstract][Full Text] [Related]
15. Molecular design, synthesis and biological research of novel pyridyl acridones as potent DNA-binding and apoptosis-inducing agents.
Zhang B; Chen K; Wang N; Gao C; Sun Q; Li L; Chen Y; Tan C; Liu H; Jiang Y
Eur J Med Chem; 2015 Mar; 93():214-26. PubMed ID: 25686590
[TBL] [Abstract][Full Text] [Related]
16. Treatment of doxorubicin-resistant MCF7/Dx cells with nitric oxide causes histone glutathionylation and reversal of drug resistance.
de Luca A; Moroni N; Serafino A; Primavera A; Pastore A; Pedersen JZ; Petruzzelli R; Farrace MG; Pierimarchi P; Moroni G; Federici G; Sinibaldi Vallebona P; Lo Bello M
Biochem J; 2011 Dec; 440(2):175-83. PubMed ID: 21834791
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel cytotoxic tetracyclic acridone derivatives and study of their molecular docking, ADMET, QSAR, bioactivity and protein binding properties.
Veligeti R; Madhu RB; Anireddy J; Pasupuleti VR; Avula VKR; Ethiraj KS; Uppalanchi S; Kasturi S; Perumal Y; Anantaraju HS; Polkam N; Guda MR; Vallela S; Zyryanov GV
Sci Rep; 2020 Nov; 10(1):20720. PubMed ID: 33244007
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of nitric oxide-releasing DDB derivatives as potential Pgp-mediated MDR reversal agents in MCF-7/Adr cells.
Tang X; Gu X; Ai H; Wang G; Peng H; Lai Y; Zhang Y
Bioorg Med Chem Lett; 2012 Jan; 22(2):801-5. PubMed ID: 22209486
[TBL] [Abstract][Full Text] [Related]
19. Targeting tyrosine kinase: Development of acridone - pyrrole - oxindole hybrids against human breast cancer.
Kaur M; Singh P
Bioorg Med Chem Lett; 2019 Jan; 29(1):32-35. PubMed ID: 30446310
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux.
Riganti C; Miraglia E; Viarisio D; Costamagna C; Pescarmona G; Ghigo D; Bosia A
Cancer Res; 2005 Jan; 65(2):516-25. PubMed ID: 15695394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
